

Author: Marcus Dawn A
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.4, Iss.10, 2003-10, pp. : 1687-1695
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Fibromyalgia: Mechanisms, Current Treatment and Animal Models
Current Pharmaceutical Biotechnology, Vol. 12, Iss. 10, 2011-10 ,pp. :


Current trends in antiglaucoma therapy
By Clark A.F.
Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. :




National trends of research in neuroscience
European Neuropsychopharmacology, Vol. 8, Iss. 4, 1998-12 ,pp. :